Serge Roche

5.3k total citations
92 papers, 4.5k citations indexed

About

Serge Roche is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Serge Roche has authored 92 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 20 papers in Cell Biology and 17 papers in Oncology. Recurrent topics in Serge Roche's work include Protein Kinase Regulation and GTPase Signaling (33 papers), PI3K/AKT/mTOR signaling in cancer (17 papers) and Chronic Myeloid Leukemia Treatments (14 papers). Serge Roche is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (33 papers), PI3K/AKT/mTOR signaling in cancer (17 papers) and Chronic Myeloid Leukemia Treatments (14 papers). Serge Roche collaborates with scholars based in France, United States and Germany. Serge Roche's co-authors include Sara A. Courtneidge, Audrey Sirvent, Manfred Koegl, Christine Bénistant, Valérie Simon, Stefano Fumagalli, Patrick Raynal, Cédric Leroy, Richard Magous and H Chapuis and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Serge Roche

88 papers receiving 4.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Serge Roche 3.1k 1.0k 839 509 392 92 4.5k
Kurt R. Auger 4.1k 1.3× 1.3k 1.3× 1.0k 1.2× 661 1.3× 289 0.7× 33 5.4k
Brian Duckworth 3.4k 1.1× 914 0.9× 1.2k 1.4× 926 1.8× 347 0.9× 15 4.9k
Rosana Kapeller 4.1k 1.3× 1.1k 1.1× 1.0k 1.2× 1.0k 2.0× 248 0.6× 41 5.9k
Bart Vanhaesebroeck 2.7k 0.9× 682 0.7× 588 0.7× 652 1.3× 226 0.6× 17 3.8k
Christopher L. Carpenter 3.7k 1.2× 583 0.6× 1.5k 1.7× 685 1.3× 218 0.6× 55 5.3k
Deborah H. Anderson 2.8k 0.9× 732 0.7× 780 0.9× 641 1.3× 183 0.5× 59 3.9k
Yasuhisa Fukui 3.4k 1.1× 801 0.8× 1.1k 1.3× 459 0.9× 141 0.4× 85 4.5k
Christine Ellis 4.2k 1.4× 1.2k 1.2× 1.1k 1.3× 796 1.6× 393 1.0× 31 5.5k
Pablo Rodriguez‐Viciana 5.2k 1.7× 1.5k 1.5× 1.1k 1.4× 731 1.4× 167 0.4× 31 6.3k
Jaime A. Escobedo 5.4k 1.7× 1.2k 1.2× 998 1.2× 771 1.5× 360 0.9× 38 7.0k

Countries citing papers authored by Serge Roche

Since Specialization
Citations

This map shows the geographic impact of Serge Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge Roche more than expected).

Fields of papers citing papers by Serge Roche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serge Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge Roche. The network helps show where Serge Roche may publish in the future.

Co-authorship network of co-authors of Serge Roche

This figure shows the co-authorship network connecting the top 25 collaborators of Serge Roche. A scholar is included among the top collaborators of Serge Roche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serge Roche. Serge Roche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naudin, Cécile, Valérie Simon, Yvan Boublik, et al.. (2025). SLAP controls mTORC2 integrity via UBE3C-mediated non-degradative mLST8 ubiquitination to suppress colorectal tumorigenesis. Cell Death and Differentiation.
2.
Giannotti, Marina I., Yvan Boublik, Anabel‐Lise Le Roux, et al.. (2025). Lipid-driven Src self-association modulates its transformation capacity. Life Science Alliance. 8(5). e202403019–e202403019.
3.
Kerneur, Clément, Valérie Simon, Yvan Boublik, et al.. (2022). Oncogenic Signalling of PEAK2 Pseudokinase in Colon Cancer. Cancers. 14(12). 2981–2981. 5 indexed citations
4.
Boublik, Yvan, Estelle Saland, Christian Récher, et al.. (2021). SHED-Dependent Oncogenic Signaling of the PEAK3 Pseudo-Kinase. Cancers. 13(24). 6344–6344. 6 indexed citations
5.
Sirvent, Audrey, et al.. (2020). Src Family Tyrosine Kinases in Intestinal Homeostasis, Regeneration and Tumorigenesis. Cancers. 12(8). 2014–2014. 17 indexed citations
6.
Sirvent, Audrey, M. Lafitte, & Serge Roche. (2018). DDR1 inhibition as a new therapeutic strategy for colorectal cancer. Molecular & Cellular Oncology. 5(4). e1465882–e1465882. 17 indexed citations
7.
Simon, Valérie, Clément Kerneur, Frédéric Allemand, et al.. (2018). Dimerization of the Pragmin Pseudo-Kinase Regulates Protein Tyrosine Phosphorylation. Structure. 26(4). 545–554.e4. 34 indexed citations
8.
Maffei, Mariano, et al.. (2015). The SH3 Domain Acts as a Scaffold for the N-Terminal Intrinsically Disordered Regions of c-Src. Structure. 23(5). 893–902. 33 indexed citations
9.
Naudin, Cécile, Audrey Sirvent, Cédric Leroy, et al.. (2014). SLAP displays tumour suppressor functions in colorectal cancer via destabilization of the SRC substrate EPHA2. Nature Communications. 5(1). 3159–3159. 38 indexed citations
10.
David, Muriel D., Cécile Naudin, Jack‐Michel Renoir, et al.. (2014). Suppressor of cytokine signaling 1 modulates invasion and metastatic potential of colorectal cancer cells. Molecular Oncology. 8(5). 942–955. 27 indexed citations
11.
Gioia, Romain, Cédric Leroy, Claire Drullion, et al.. (2011). Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells. Blood. 118(8). 2211–2221. 75 indexed citations
12.
Leroy, Cédric, Audrey Sirvent, Valérie Simon, et al.. (2009). Quantitative Phosphoproteomics Reveals a Cluster of Tyrosine Kinases That Mediates Src Invasive Activity in Advanced Colon Carcinoma Cells. Cancer Research. 69(6). 2279–2286. 93 indexed citations
13.
Paronetto, Maria Paola, Sandrine Opi, Stéphane Audebert, et al.. (2009). Alternative Splicing Modulates Autoinhibition and SH3 Accessibility in the Src Kinase Fyn. Molecular and Cellular Biology. 29(24). 6438–6448. 28 indexed citations
14.
García-Martínez, José Manuel, Annarica Calcabrini, Lorena González, et al.. (2009). A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling. Cellular Signalling. 22(3). 415–426. 36 indexed citations
15.
Mahon, François‐Xavier, Sandrine Hayette, Valérie Lagarde, et al.. (2008). Evidence that Resistance to Nilotinib May Be Due to BCR-ABL, Pgp, or Src Kinase Overexpression. Cancer Research. 68(23). 9809–9816. 174 indexed citations
16.
Franco, Mélanie, et al.. (2006). The Adaptor Protein Tom1L1 Is a Negative Regulator of Src Mitogenic Signaling Induced by Growth Factors. Molecular and Cellular Biology. 26(5). 1932–1947. 34 indexed citations
17.
Yart, Armelle, Muriel Laffargue, Patrick Mayeux, et al.. (2001). A Critical Role for Phosphoinositide 3-Kinase Upstream of Gab1 and SHP2 in the Activation of Ras and Mitogen-activated Protein Kinases by Epidermal Growth Factor. Journal of Biological Chemistry. 276(12). 8856–8864. 124 indexed citations
19.
Roche, Serge, Gema Alonso, Andrius Kazlauskas, et al.. (1998). Src-like adaptor protein (Slap) is a negative regulator of mitogenesis. Current Biology. 8(17). 975–978. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026